CMG Global Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$551K Sell
19,317
-600
-3% -$16K 0.24% 58
2026
Q2
$480K Buy
19,917
+350
+2% +$9.16K 0.2% 62
2026
Q1
$549K Buy
19,567
+100
+0.5% +$2.66K 0.26% 58
2025
Q4
$521K Sell
19,467
-922
-5% -$23.3K 0.23% 59
2025
Q3
$497K Buy
20,389
+360
+2% +$8.89K 0.24% 59
2025
Q2
$487K Sell
20,029
-223
-1% -$5.2K 0.26% 57
2025
Q1
$461K Buy
20,252
+1,975
+11% +$51.7K 0.3% 55
2024
Q4
$475K Buy
18,277
+2,927
+19% +$79.4K 0.26% 59
2024
Q3
$444K Sell
15,350
-100
-0.6% -$2.92K 0.25% 63
2024
Q2
$432K Sell
15,450
-1,346
-8% -$37.1K 0.29% 58
2024
Q1
$466K Buy
16,796
+173
+1% +$4.8K 0.32% 55
2023
Q4
$457K Sell
16,623
-81
-0.5% -$2.45K 0.33% 58
2023
Q3
$554K Buy
16,704
+1,873
+13% +$66.2K 0.47% 49
2023
Q2
$544K Hold
14,831
– – 0.44% 52
2023
Q1
$605K Sell
14,831
-17,514
-54% -$756K 0.55% 45
2022
Q4
$1.66M Sell
32,345
-229
-0.7% -$11K 1.57% 18
2022
Q3
$1.42M Sell
32,574
-1,648
-5% -$80.1K 1.54% 23
2022
Q2
$1.79M Sell
34,222
-3,088
-8% -$157K 1.86% 17
2022
Q1
$1.93M Sell
37,310
-40,263
-52% -$2.09M 1.58% 20
2021
Q4
$4.58M Sell
77,573
-5,160
-6% -$256K 2.95% 8
2021
Q3
$3.56M Sell
82,733
-663
-0.8% -$29.4K 2.66% 11
2021
Q2
$3.27M Buy
83,396
+70,534
+548% +$2.74M 2.46% 12
2021
Q1
$466K Hold
12,862
– – 0.4% 54

Other funds holding PFE

CMG Global Holdings's PFE Position: Q3 2026 in Review

CMG Global Holdings reduced its Pfizer (PFE) stake by 3% in Q3 2026, selling an estimated $16K and leaving 19,317 shares worth $551K. The position accounts for 0.24% of the portfolio, ranked #58.

CMG Global Holdings first reported a position in PFE in Q1 2021 and has held it in 23 quarters since. The position peaked at $4.58M in Q4 2021. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • CMG Global Holdings held 19,317 shares of Pfizer worth $551K as of Q3 2026.
  • CMG Global Holdings sold 600 Pfizer shares in Q3 2026, an estimated $16K.
  • Pfizer made up 0.24% of CMG Global Holdings's portfolio in Q3 2026, its #58 holding.
  • CMG Global Holdings first reported a position in Pfizer in Q1 2021 and has held it in 23 quarters since.
  • CMG Global Holdings's Pfizer position peaked at $4.58M in Q4 2021.
  • 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on CMG Global Holdings's 13F filing for Q3 2026, filed 14 Oct 2026.